FindTrial
Sign In

The investigation of neuropeptide SP and miR-103a in the development process of epiphyseal cartilage in developmental dysplasia of the hip

The investigation of neuropeptide SP and miR-103a in the development process of epiphyseal cartilage in developmental dysplasia of the hip

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BPC-16009393
Enrollment
Unknown
Registered
2016-10-13
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental dysplasia of the hip, DDH

Interventions

Three groups:Nil

Sponsors

Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Patients of DDH with 30-45 years old or patients of transcervical fracture with 40-50 years old in our hospital; 2.Female patients; 3.DDH with osteoarthritis in hip joint

Exclusion criteria

Exclusion criteria: 1.Patients ever went through hip joint surgery 2.Patients with endocrine and metabolic diseases

Design outcomes

Primary

MeasureTime frame
hip joint center-edge angle;—

Countries

China

Contacts

Public ContactChen Xiaodong

Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine

chenxdmd@163.com+86 13482888883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026